FDA Determines Regulatory Review Period for SIMPLIFY CERVICAL ARTIFICIAL DISC

Summary

The US Food and Drug Administration (FDA) has published a notice determining the regulatory review period for patent extension of SIMPLIFY CERVICAL ARTIFICIAL DISC, a medical device, following submissions to the US Patent and Trademark Office (USPTO).